News & Updates

Weight loss with tirzepatide reversed after stopping treatment

16 Dec 2023 by

For individuals with overweight or obesity who are taking tirzepatide for weight management, continued treatment results in sustained and even augmented weight loss. When treatment is stopped, however, the achieved weight loss is substantially reversed.

Weight loss with tirzepatide reversed after stopping treatment

16 Dec 2023

Antiplatelet therapy de-escalation a promising strategy for East Asian patients undergoing PCI

15 Dec 2023

De-escalation of antiplatelet therapy appears to yield more favourable outcomes compared with standard dual antiplatelet therapy (DAPT) in East Asian patients with acute coronary syndrome (ACS) who are undergoing percutaneous coronary intervention (PCI), as shown in a study.

Antiplatelet therapy de-escalation a promising strategy for East Asian patients undergoing PCI

15 Dec 2023

Getting both COVID-19 and flu shots at once just as effective as separate vaccinations

15 Dec 2023 by

Coadministration of the BNT162b2 BA.4/5 bivalent mRNA COVID-19 vaccine (BNT162b2-biv) and the seasonal influenza vaccine (SIV) offers protection against the two infections, with an efficacy that is similar as when giving each vaccine alone, according to a study.

Getting both COVID-19 and flu shots at once just as effective as separate vaccinations

15 Dec 2023

Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals

15 Dec 2023 by

Baricitinib, ivermectin, and favipiravir stood out in terms of efficacy in a network meta-analysis evaluating various novel oral antivirals for the treatment of COVID-19.

Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals

15 Dec 2023

Teplizumab preserves ß-cell function in children with new-onset T1D

15 Dec 2023 by

Treatment with teplizumab significantly preserved beta(ß)-cell function, as measured by C-peptide levels, in children and adolescents with new-onset type 1 diabetes (T1D) compared with placebo, according to the PROTECT* study.

Teplizumab preserves ß-cell function in children with new-onset T1D

15 Dec 2023

Very early HIV treatment may help babies live medication-free

13 Dec 2023 by

Initiating antiretroviral therapy (ART) within 48 hours of life for infants born with HIV can lead to sustained viral suppression, as reflected by reduced HIV reservoirs by age 2 years, which suggests the possibility of an ART-free remission.

Very early HIV treatment may help babies live medication-free

13 Dec 2023

MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC

13 Dec 2023 by

In the second interim analysis of the Asian cohort from the phase III MAGNITUDE study, a combination regimen comprising niraparib and abiraterone acetate plus prednisone (NIRA-AAP) improved clinical outcomes in patients with BRCA+ metastatic castration-resistant prostate cancer (mCRPC).

MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC

13 Dec 2023

Levothyroxine falls short of increasing heart transplant rates in brain-dead donors

12 Dec 2023

In haemodynamically unstable brain-dead potential heart donors, the use of levothyroxine infusion appears to be only as good as saline infusion in terms of the rate of hearts being transplanted, according to a study.

Levothyroxine falls short of increasing heart transplant rates in brain-dead donors

12 Dec 2023

BPaLM regimen continues to show benefit against rifampicin-resistant tuberculosis

12 Dec 2023 by

In the treatment of patients with rifampicin-resistant tuberculosis, a 6-month oral regimen consisting of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) is safe and efficacious and compares favourably with standard of care, as shown in the final data from the phase IIB-III TB-PRACTECAL study.

BPaLM regimen continues to show benefit against rifampicin-resistant tuberculosis

12 Dec 2023

Molecular-based guided therapy shows promise in treatment-resistant HCC/H-CCK

12 Dec 2023

A recent study has demonstrated the feasibility of molecular-based targeted therapy in patients with hepatocellular carcinoma (HCC)/hepato-cholangiocarcinoma (H-CCK) that progressed while under treatment with atezolizumab/bevacizumab.

Molecular-based guided therapy shows promise in treatment-resistant HCC/H-CCK

12 Dec 2023

News & Updates

Filter by Specialty:

Specialty:

Weight loss with tirzepatide reversed after stopping treatment

Weight loss with tirzepatide reversed after stopping treatment

Antiplatelet therapy de-escalation a promising strategy for East Asian patients undergoing PCI

Antiplatelet therapy de-escalation a promising strategy for East Asian patients undergoing PCI

Getting both COVID-19 and flu shots at once just as effective as separate vaccinations

Getting both COVID-19 and flu shots at once just as effective as separate vaccinations

Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals

Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals

Teplizumab preserves ß-cell function in children with new-onset T1D

Teplizumab preserves ß-cell function in children with new-onset T1D

Very early HIV treatment may help babies live medication-free

Very early HIV treatment may help babies live medication-free

MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC

MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC

Levothyroxine falls short of increasing heart transplant rates in brain-dead donors

Levothyroxine falls short of increasing heart transplant rates in brain-dead donors

BPaLM regimen continues to show benefit against rifampicin-resistant tuberculosis

BPaLM regimen continues to show benefit against rifampicin-resistant tuberculosis

Molecular-based guided therapy shows promise in treatment-resistant HCC/H-CCK

Molecular-based guided therapy shows promise in treatment-resistant HCC/H-CCK